Cargando…
Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines
Background: The outbreak of new coronavirus has tremendously threatened the public health system worldwide, including China. Chinese patent medicines (CPMs) have greatly contributed to the prevention and treatment of this viral infection, as well as the recovery of patients with COVID-19 infection....
Autores principales: | Wu, Ying, Zhong, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443789/ https://www.ncbi.nlm.nih.gov/pubmed/34539389 http://dx.doi.org/10.3389/fphar.2021.655063 |
Ejemplares similares
-
Role of Traditional Chinese Medicine in the Management of Viral Pneumonia
por: Xi, Shengyan, et al.
Publicado: (2020) -
Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine
por: Luo, Chuan-hong, et al.
Publicado: (2020) -
Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China
por: Zhuang, Wei, et al.
Publicado: (2020) -
Progress in Traditional Chinese Medicine Against Respiratory Viruses: A Review
por: Li, Bao-Hong, et al.
Publicado: (2021) -
Quantitative Determination and Toxicity Evaluation of Aristolochic Acid Analogues in Asarum heterotropoides F. Schmidt (Xixin) and Traditional Chinese Patent Medicines
por: Liu, Suyan, et al.
Publicado: (2021)